Strengths

● The stock, which is currently worth 2019 to 0.63 times its sales, is clearly overvalued in comparison with peers.

● This company will be of major interest to investors in search of a high dividend stock.

● The stock is in a well-established, long-term rising trend above the technical support level at 5.41 EUR


Weaknesses

● The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.

● The stock is close to a major daily resistance at EUR 5.94, which should be gotten rid of so as to gain new appreciation potential.

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company sustains low margins.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 33.87 times its estimated earnings per share for the ongoing year.

● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.